![Daryl DeKarske](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daryl DeKarske
General Counsel bei
NEUREN PHARMACEUTICALS LIMITED
Profil
Daryl DeKarske is currently Director at Screening for Mental Health, Inc. and Chief Regulatory Officer at Neuren Pharmaceuticals Ltd. Starting in 2025, the role at Neuren Pharmaceuticals Ltd. is ongoing.
Former roles include Senior Vice President-Global Regulatory Affairs at Horizon Therapeutics USA, Inc. from 2022 to 2024, Senior Vice President and Head of Global Regulatory Affairs at ACADIA Pharmaceuticals, Inc. from 2017 to 2022, and Vice President, Head of Neurology, Ophthalmology & Oncology at Shire Plc from 2010 to 2017.
Education includes undergraduate and graduate degrees from the University of Michigan.
Aktive Positionen von Daryl DeKarske
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | General Counsel | 02.05.2025 |
Screening for Mental Health, Inc.
 Screening for Mental Health, Inc. Medical/Nursing ServicesHealth Services Provides mental health care services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Daryl DeKarske
| Unternehmen | Position | Ende |
|---|---|---|
Horizon Therapeutics USA, Inc.
 Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief arthritis | General Counsel | 01.02.2024 |
| ACADIA PHARMACEUTICALS INC. | General Counsel | 01.11.2022 |
| SHIRE | Corporate Officer/Principal | 01.01.2017 |
Ausbildung von Daryl DeKarske
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Neuren Pharmaceuticals Ltd.
 Neuren Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Manufactures drugs for neurological disorders | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Horizon Therapeutics USA, Inc.
Horizon Therapeutics USA, Inc. Pharmaceuticals: MajorHealth Technology Develops prescription drugs for mild to moderate pain relief arthritis | Health Technology |
Screening for Mental Health, Inc.
Screening for Mental Health, Inc. Medical/Nursing ServicesHealth Services Provides mental health care services | Health Services |
